Portfolio

Psyomics has created a digital mental health assessment tool, Censeo, delivering a psychiatrist quality mental health assessment to reduce misdiagnosis and get patients treatment quicker, whilst improving GP and psychiatry efficiency.

Accelercomm is a leader in high-performance wireless communications solutions and has developed patented communications algorithms for 5G, doubling network capacity whilst halving power consumption and slashing latency.

ACAL Energy is a chemical company developing and licensing a platinum free liquid catalyst, FlowCath®. As the world's leading developer of low cost Proton Exchange Membrane (PEM) technology, they are revolutionising fuel cells for automotive and stationary power applications.

8Power specialises in self-powered wireless sensor solutions for industrial plant applications. The technology provides a proactive, early warning and remote monitoring solution for a range of industrial plant equipment.

52 North Health is developing the world’s first finger-prick blood test to measure white blood cell count and blood lactate for chemotherapy patients at risk. They create in-vitro diagnostic and digital solutions to improve emergency care.

1715 Labs is a data labelling platform that helps AI reach its full potential by structuring data for effective analysis, combining human input with advanced statistical tools to provide rapid, cost-effective training, labelling, and analysis.

MeVitae has developed software to streamline recruitment processes, using data-driven technology to attract, screen and retain top talent whilst building diverse and productive teams fairly. The software aims to eliminate 15 bias parameters using its suite of Artificial Intelligence-based solutions.

Phasecraft is a team of world leading quantum scientists and engineers, tackling ambitious problems by accelerating the practical application of quantum computing.

Concr is a value-driven techbio company, spun out of the University of Cambridge, applying statistical learning and advanced modelling adopted from astrophysics to aid in the precision treatment of cancer patients. Concr’s online platform allows the storage, management and analysis of data generating actionable insights for cost-effective drug development and patient treatment.

Mint Neurotechnologies Ltd (MintNeuro) is an innovative startup at the dynamic intersection of neurotechnology and semiconductors. MintNeuro is pioneering integrated circuit solutions for implantable medical devices targeting the management and treatment of neurological conditions. MintNeuro’s goal is to deliver scalable, less invasive, and highly efficient devices that transform neurological care.

Founded in 2020, Bitfount democratises federated AI infrastructure for clinical research, enabling secure collaboration without data sharing. The company’s platform connects healthcare providers, pharmaceutical companies, and CROs through privacy-preserving AI networks.

Oxa is an autonomous vehicle software company whose technology operates in any location with zero dependence on external systems i.e. no GPS and no third-party maps. Its autonomous control system, Selenium, is a suite of software that combines data from vehicle sensors to drive autonomous vehicles. The Company’s cloud-based fleet management system, Caesium, schedules and co-ordinates autonomous vehicles, optimising routes and exchanging data without human intervention.

adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation, reducing refining and partially replacing costly and potentially harmful human trials.

DeepForm‘s novel press tool designs for automotive and other high volume customers, suited to a wide range of steel and aluminium panels. DeepForm’s fold-shear process replaces the draw stage in a conventional cold stamping line-up. In one tool, regions of the part are folded whilst soaking up material in customised 3-D blankholders, before completing the operation.

PetMedix is utilising tried and tested antibody technology to develop treatments for diseases in companion animals. Monoclonal antibodies are now a hugely important human drug class but are in their infancy in the treatment of animals. PetMedix will take tried and tested techniques and apply them to the treatment of dogs and cats.